U.S., May 15 -- ClinicalTrials.gov registry received information related to the study (NCT07587684) titled 'A Study of IN026 in Participants With Refractory Gout' on April 24.
Brief Summary: The goal of this clinical study is to learn if IN026 Injection is safe and works to lower uric acid levels in adults with refractory gout (gout that does not respond well to standard treatments). The main questions it aims to answer are:
* What medical problems do participants have when taking IN026, such as changes in vital signs, blood tests, or heart rhythm?
* How does the body absorb, process, and respond to IN026, and does it trigger an immune reaction?
* Does IN026 lower uric acid levels in the blood and reduce tophi?
Investigator will start ...